Le médecin généraliste face aux naevi = General practitioner facing molesBOURDEAUD'HUI, F; DEL MARMOL, V.Revue médicale de Bruxelles. 2011, Vol 32, Num 4, pp 205-209, issn 0035-3639, 5 p.Conference Paper

Comparison of HPLC and stereologic image analysis for the quantitation of Eu- and pheomelanins in nevus cells and stimulated melanoma cellsDONOIS, E; DEL MARMOL, V; GHANEM, G et al.Journal of investigative dermatology. 1998, Vol 111, Num 3, pp 422-428, issn 0022-202XArticle

Que faire devant un ulcère du pied chez un patient diabétique ? = What is the management for foot ulcers in diabetic patients ?HEUREUX, M; DE WILDE, J.-P; STALLENBERG, B et al.Revue médicale de Bruxelles. 2009, Vol 30, Num 1, pp 29-35, issn 0035-3639, 7 p.Article

Molecular characterization of a human tyrosinase-related-protein-2 cDNA : patterns of expression in melanocytic cellsBOUCHARD, B; DEL MARMOL, V; JACKSON, I. J et al.European journal of biochemistry (Print). 1994, Vol 219, Num 1-2, pp 127-134, issn 0014-2956Article

Glutathione depletion in mouse melanoma cells increases their sensitivity to oxidative lysisPEINADO, P; MARTINEZ-LIARTE, J. H; DEL MARMOL, V et al.The Cancer journal (Print). 1992, Vol 5, Num 6, pp 348-353, issn 0765-7846Article

Melanoma incidence and mortality in Europe: new estimates, persistent disparitiesFORSEA, A. M; DEL MARMOL, V; DE VRIES, E et al.British journal of dermatology (1951). 2012, Vol 167, Num 5, pp 1124-1130, issn 0007-0963, 7 p.Article

Primary Cutaneous Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Recipients: A Multicenter European Case SeriesSECKIN, D; BARETE, S; GÜLEC, A. T et al.American journal of transplantation (Print). 2013, Vol 13, Num 8, pp 2146-2153, issn 1600-6135, 8 p.Article

Current guidelines in melanoma treatmentBROCHEZ, L; VERHAEGHE, E; SALES, F et al.Dermatology (Basel). 2000, Vol 200, Num 2, pp 160-166, issn 1018-8665Conference Paper

A Prime minister managed to attract elderly men in a Belgian Euromelanoma campaignDEL MARMOL, V; DE VRIES, E; ROSEEUW, D et al.European journal of cancer (1990). 2009, Vol 45, Num 9, pp 1532-1534, issn 0959-8049, 3 p.Article

Partial characterization of IR-α-MSH peptides found in melanoma tumorsGHANEM, G; LOIR, B; HADLEY, M et al.Peptides (New York, NY. 1980). 1992, Vol 13, Num 5, pp 989-994, issn 0196-9781Article

African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinismDURHAM-PIERRE, D; GARDNER, J. M; NAKATSU, Y et al.Nature genetics. 1994, Vol 7, Num 2, pp 176-180, issn 1061-4036Article

Glutathione depletion increases tyrosinase activity in human melanoma cellsDEL MARMOL, V; SOLANO, F; SELS, A et al.Journal of investigative dermatology. 1993, Vol 101, Num 6, pp 871-874, issn 0022-202XArticle